Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
LYEL | Lyell Immunopharma, Inc. | Chief Financial Officer | $208K | +$112K | +116% | Mar 17, 2025 |
TSVT | 2seventy bio, Inc. | Director | $142K | Jun 10, 2024 | ||
CHRS | Coherus BioSciences, Inc. | Director | Jun 3, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|